Cohlhepp Ryaninsider trades
In SEC Form 4 filings, Cohlhepp Ryan is listed as President, COO & Interim CEO of Bicara Therapeutics Inc. (BCAX). In the last 90 days, Cohlhepp Ryan sold $400.7K of Bicara Therapeutics Inc. (BCAX) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| BCAXBicara Therapeutics Inc. | President, COO & Interim CEO | 4 | Sep 10 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-10
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| BCAXBicara Therapeutics Inc. | Sep 8 | Sep 10 | M | 17,500 | $3.79 | $66,322 | 199,141 | Yes | Form 4 |
| BCAXBicara Therapeutics Inc. | Sep 8 | Sep 10 | S | 14,058 | $22.77 | Sale −$320,053 | 185,083 | Yes | Form 4 |
| BCAXBicara Therapeutics Inc. | Sep 8 | Sep 10 | S | 3,442 | $23.43 | Sale −$80,663 | 181,641 | Yes | Form 4 |
| BCAXBicara Therapeutics Inc. | Sep 8 | Sep 10 | M · derivative | 17,500 | $3.79 | $66,322 | 34,252 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.